oral-child TDLo 21 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION Journal of Toxicology, Clinical Toxicology. Vol. 30, Pg. 413, 1992.
oral-child TDLo 300 mg/kg/5D-I VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Pediatric Emergency Care. Vol. 10, Pg. 344, 1994.
intravenous-guinea pig LDLo 65 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 130, Pg. 235, 1961.
intravenous-human TDLo 23 mg/kg BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA Archiv fuer Toxikologie. Vol. 28, Pg. 72, 1971.
intravenous-man TDLo 1700 ug/kg/2M- LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
CARDIAC: PULSE RATE
BEHAVIORAL: COMA American Journal of Emergency Medicine. Vol. 4, Pg. 143, 1986.
intravenous-man TDLo 8643 ug/kg/4H- BEHAVIORAL: TOXIC PSYCHOSIS Annals of Internal Medicine. Vol. 97, Pg. 149, 1982.
intraperitoneal-mouse LD50 102 mg/kg PERIPHERAL NERVE AND SENSATION: LOCAL ANESTHETIC
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA Journal of Medicinal Chemistry. Vol. 24, Pg. 1059, 1981.
intravenous-mouse LD50 20 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Journal of Pharmacology and Experimental Therapeutics. Vol. 123, Pg. 269, 1958.
oral-mouse LD50 220 mg/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: REGIDITY Arzneimittel-Forschung. Drug Research. Vol. 16, Pg. 1275, 1966.
intravenous-rabbit LDLo 41 mg/kg Acta Pharmacologica et Toxicologica. Vol. 31, Pg. 273, 1972.
intraperitoneal-rat LD50 133 mg/kg LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Archives Internationales de Pharmacodynamie et de Therapie. Vol. 243, Pg. 97, 1980.
intravenous-rat LD50 18 mg/kg United States Patent Document. Vol. #5264432
oral-rat LD50 317 mg/kg Bollettino Chimico Farmaceutico. Vol. 110, Pg. 330, 1971.
unreported-rat LD50 39400 ug/kg Farmakologiya i Toksikologiya Vol. 54(3), Pg. 32, 1991.
|
subcutaneous-guinea pig LD50 120 mg/kg Farmaco, Edizione Scientifica. Vol. 10, Pg. 883, 1955.
subcutaneous-mouse LD50 238 mg/kg Journal of Medicinal Chemistry. Vol. 28, Pg. 714, 1985.
subcutaneous-rat LD50 335 mg/kg European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 9, Pg. 188, 1974.
|